Investing.comDoubao · 实盘不做把握 8/10不做原因:无增量信息
北京时间·🕒 发布 19:04:35·⟳ 抓取 19:05:02 +27s·⚡ 决策 10-12 19:06:08 +1m06s·15.1 天前
Harmony Biosciences 任命现任 COO Peter Anastasiou 为下一任 CEO，2027年1月1日生效，现任 CEO Dayno 按计划退休，同时重申全年 WAKIX 指引不变
这是一次计划内、内部继承的例行 CEO 交接：继任者已任 COO 并曾任董事，过渡安排清晰（Dayno 退休后留任顾问全年），公司同时重申 WAKIX 全年指引并声明关键里程碑时点不变。既无控制权变更、战略转向、指引调整，也无管理层动荡或关键人断裂，属连续性事件，没有方向性 edge，多空皆不成立。
📄 原文Investing.com↗ 原文
Harmony Biosciences names Peter Anastasiou as next CEO
By Investing.com Advertisement Advertisement Harmony Biosciences names Peter Anastasiou as next CEO Company News Publis…
不做 Harmony Biosciences Holdings, Inc.（HRMY.US）
计划内、内部继承的例行 CEO 交接，控制权与战略连续，公司重申 2026 WAKIX 指引（10.0–10.4 亿美元）且关键里程碑时点不变，无盈利/估值增量与预期差；既无强多催化也不构成强空催化，不做多也不做空。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
HRMY 宣布现任 COO Anastasiou 接棒、Dayno 按计划退休，属内部有序接班且重申指引、里程碑时点不变；无预期差、无净利好或净利空，不产生可交易机会，AVOID。
🔎 新鲜度:最早出现 2026-10-12 · 扩散 low · price-in 风险 low ↗
主要风险
- 唯一具股价敏感性的增量在 BP-205（多剂量递增）2026Q4 数据与 WAKIX 独占权保护，本次 CEO 新闻未提供任何新信息，不能据此提前布局。
- 美股当前处于盘前（美东 07:05），即便市场对该人事有轻微情绪反应也缺乏基本面支撑，追高或反向做空均无依据。
反向证据
- 做多前查反向 · 来源 web · 日期 2026-10-12 · 影响 none
正文明确重申全年指引且不预期关键商业/管线时点变化，未附带任何指引上调、新订单或超预期内容，无做多催化。
检索:Harmony Biosciences CEO change strategy guidance revision BP-205 WAKIX setback 原文 ↗ - 做空前查反向 · 来源 web · 日期 2026-10-12 · 影响 none
Dayno 为任职九年后的计划退休，继任者为现任 COO/前董事，创始人董事长 Aronin 留任并公开背书，无突发离职、控制权或治理断裂，不满足做空红线。
检索:Harmony Biosciences CEO departure sudden resignation governance turmoil key person 原文 ↗
先例如何影响了这次决策
对本次决策的影响:未改变结论：此类连续性人事事件本身无 edge，直接 AVOID，故不构建先例面板。
方向:无高价值先例可测：计划内、内部继承且战略/指引连续的例行 CEO 交接，历史上通常不产生显著方向性漂移，偶发波动属情绪噪声，不构成可复用的胜率/幅度基准。
涨幅量级:无对齐先例，且事件无盈利或指引增量，不足以也不需要校准止盈幅度。
形态:无可识别的见光死或趋势模式可迁移至本次。
工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 12 ms
{"result": "search_processed_events:agent query=`harmony biosciences names next ceo january 2027 wakix guidance | harmony biosciences peter anastasiou ceo successor | hrmy jeffrey dayno retirement ceo announcement`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 0.0/72 小时、0 条本臂决策(完整)，返回 0 条候选。未命中只表示这些 agent query 表达式没有召回候
原文全文
展开原文 · 7,451 字
Harmony Biosciences names Peter Anastasiou as next CEO By Investing.com
Advertisement
Advertisement
Harmony Biosciences names Peter Anastasiou as next CEO
Company News
Published
Oct 12, 2026, 07:04 AM
Harmony Biosciences names Peter Anastasiou as next CEO
View all comments (0)
0
Harmony Biosciences names Peter Anastasiou as next CEO
View all comments (0)
0
© Reuters
In this article:
HRMY
+
1.72%
PLYMOUTH MEETING, Pa. -
Harmony Biosciences Holdings
, Inc. (
NASDAQ:HRMY
) announced Monday that Peter Anastasiou will become President and Chief Executive Officer effective January 1, 2027, according to a press release statement.
Anastasiou, currently serving as Senior Executive Vice President and Chief Operating Officer, will succeed Jeffrey M. Dayno, M.D., who will retire as President and CEO on December 31, 2026, after nine years with the company. Dayno will serve as a non-executive advisor throughout 2027.
Anastasiou previously served on Harmony’s Board of Directors for three years before joining as COO. He was Chief Executive Officer of Capsida Biotherapeutics for nearly four years, where he raised more than $165 million in capital and secured partnerships with AbbVie and Lilly. Prior to that, he served as Executive Vice President and President of North America at Lundbeck, leading an organization of approximately 1,200 employees with annual net revenues exceeding $1.5 billion.
The company reiterated its full-year 2026 WAKIX net revenue guidance of $1.0 billion to $1.04 billion. Harmony stated it remains on track to report data from the multiple ascending dose study of BP-205 in the fourth quarter of 2026.
"Peter is the right leader for Harmony’s next phase of growth," said Jeffrey S. Aronin, founder and Chairman of the Board. "He has a deep understanding of our business and has been an important contributor to our strategy, pipeline and business development efforts."
Harmony stated it remains focused on growing the pitolisant franchise, advancing its CNS pipeline, deploying capital strategically, and protecting WAKIX exclusivity. The company does not currently expect changes in the timing of key commercial and pipeline milestones.
Anastasiou holds an M.B.A. from the Kelley School of Business at Indiana University and a B.A. in economics and management from Albion College.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Harmony Biosciences names Peter Anastasiou as next CEO
View all comments (0)
0
Latest comments
Post
Comment Guidelines
Trade With A Regulated Broker
Indices
Commodities
Bonds
Stocks
US 30
51,695.50
+40.3
+0.08%
US 500
7,813.70
+2.2
+0.03%
Dow Jones
51,654.95
+423.31
+0.83%
S&P 500
7,811.54
+46.18
+0.59%
Nasdaq
27,366.17
+172.83
+0.64%
S&P 500 VIX
15.50
+0.66
+4.45%
Dollar Index
102.21
+0.188
+0.18%
Crude Oil WTI Futures
92.90
+1.05
+1.14%
Brent Oil Futures
105.95
+1.23
+1.17%
Natural Gas Futures
3.145
-0.075
-2.33%
Gold Futures
4,199.51
-16.79
-0.40%
Silver Futures
60.898
-0.151
-0.25%
Copper Futures
6.7673
+0.0753
+1.13%
US Soybeans Futures
1,282.88
-8.13
-0.63%
U.S. 10Y
5.256
+0.012
+0.23%
U.S. 30Y
5.599
-0.008
-0.14%
U.S. 5Y
5.021
+0.030
+0.60%
U.S. 3M
4.159
+0.008
+0.19%
US 10Y T-Note Futures
104.53
-0.06
-0.06%
Euro Bund Futures
121.05
-0.03
-0.03%
10-2 Yield Spread
31.32
+4.15
+15.27%
AAPL
336.64
-3.78
-1.11%
NVDA
229.28
-1.20
-0.52%
GOOGL
351.66
+3.37
+0.97%
TSLA
382.70
+7.70
+2.05%
AMZN
262.43
+8.37
+3.29%
NFLX
70.30
-1.27
-1.77%
META
718.67
-2.22
-0.31%
Advertisement
Most Popular Articles
News
Analysis
Oil falls, CPI and bank earnings in focus - what’s moving markets
By Investing.co
...
Oct 12, 2026
8 emerging markets to consider in 2027: HSBC
By Investing.co
...
Oct 11, 2026
What the sell off in bonds means for monetary policy
By Investing.co
...
Oct 11, 2026
Broadcom CEO says many AI investors are gamblers
By Investing.co
...
Oct 12, 2026
Premarket movers: Iren jumps on Anthropic deal, CCC surges on buyout talks
By Investing.co
...
Oct 12, 2026
Sequence of Return Risk: The Math That Breaks Retirements
By Lance Robert
...
Oct 10, 2026
Beyond Chips: The 3 Layers of the AI Value Chain
By Ivana Delevs
...
Oct 10, 2026
OpenAI’s $20B Revenue Gap: Warning Signs for US Stocks?
By Lee Yang
Oct 09, 2026
Wall Street’s Busy Week: Bank Results, CPI and Retail Sales in Focus
By Ali Merchant
Oct 12, 2026
Treasury Auctions Explained: Why Bond Auctions Matter Even If You Dont Trade Bonds
By Matthew Well
...
Oct 10, 2026
More News
Market Movers
Most Active
Gainers %
Losers %
Name
Last
Chg. %
Vol.
MU
1,029.00
-0.66%
19.92M
NVDA
229.28
-0.52%
84.65M
SPCX
162.57
+1.25%
93.04M
TSLA
382.70
+2.05%
38.95M
AAPL
336.64
-1.11%
37.88M
MSFT
535.07
+2.38%
18.50M
AMZN
262.43
+3.29%
34.77M
Name
Last
Chg. %
Vol.
CCI
79.64
+15.60%
14.39M
MRNA
225.00
+14.21%
28.95M
HUM
431.87
+11.56%
4.99M
AMT
182.24
+9.30%
8.51M
SBAC
182.49
+7.34%
2.36M
DDOG
293.26
+7.11%
3.71M
AKAM
106.95
+6.00%
5.80M
Name
Last
Chg. %
Vol.
TMUS
148.58
-13.27%
19.03M
T
22.18
-10.82%
150.53M
VZ
41.65
-10.14%
95.17M
HPQ
30.20
-6.91%
16.70M
FMC
8.35
-6.39%
5.19M
CHTR
103.38
-5.74%
5.11M
FICO
667.58
-5.63%
1.09M
Advertisement
Trending Stocks
Name
Last
Chg. %
Vol.
MU
1,029.00
-0.66%
19.92M
NVDA
229.28
-0.52%
84.65M
SPCX
162.57
+1.25%
93.04M
PLTR
209.05
+5.17%
37.62M
IREN
35.190
-1.46%
38.53M
Show more
Advertisement
ProPicks AI
AI-powered
stock picks
with a proven track record to
beat the S&P 500
.
Tech Titans
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Top Value Stocks
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Best of Buffett
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Energy Elite
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Financial Fortresses
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Quality Compounders
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Small-Cap Sprinters
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Healthcare Heroes
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Beat the S&P 500
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Dominate the Dow
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Mid-Cap Movers
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Mexican Stock Exchange Leaders
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Best Brazilian Stocks
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Italian Market Elite
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Alpha Germany Select
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Comments
Post
Comment Guidelines
Tools
Calendars
Economic Calendar
Earnings Calendar
Holiday Calendar
US Economy
Fed Rate Monitor Tool
US Treasury Yield Curve
More Tools
Stock Screener
Currency Converter
Markets
Ask WarrenAI
Stocks Picked by AI
Watchlist
Alerts
Top Brokers
Breaking News
Tools
Install Our App
Scan QR code to install app
Follow us
Advertisement
Advertisement
Harmony Biosciences names Peter Anastasiou as next CEO
Company News
Published
Oct 12, 2026, 07:04 AM
Harmony Biosciences names Peter Anastasiou as next CEO
View all comments (0)
0
Harmony Biosciences names Peter Anastasiou as next CEO
View all comments (0)
0
© Reuters
In this article:
HRMY
+
1.72%
PLYMOUTH MEETING, Pa. -
Harmony Biosciences Holdings
, Inc. (
NASDAQ:HRMY
) announced Monday that Peter Anastasiou will become President and Chief Executive Officer effective January 1, 2027, according to a press release statement.
Anastasiou, currently serving as Senior Executive Vice President and Chief Operating Officer, will succeed Jeffrey M. Dayno, M.D., who will retire as President and CEO on December 31, 2026, after nine years with the company. Dayno will serve as a non-executive advisor throughout 2027.
Anastasiou previously served on Harmony’s Board of Directors for three years before joining as COO. He was Chief Executive Officer of Capsida Biotherapeutics for nearly four years, where he raised more than $165 million in capital and secured partnerships with AbbVie and Lilly. Prior to that, he served as Executive Vice President and President of North America at Lundbeck, leading an organization of approximately 1,200 employees with annual net revenues exceeding $1.5 billion.
The company reiterated its full-year 2026 WAKIX net revenue guidance of $1.0 billion to $1.04 billion. Harmony stated it remains on track to report data from the multiple ascending dose study of BP-205 in the fourth quarter of 2026.
"Peter is the right leader for Harmony’s next phase of growth," said Jeffrey S. Aronin, founder and Chairman of the Board. "He has a deep understanding of our business and has been an important contributor to our strategy, pipeline and business development efforts."
Harmony stated it remains focused on growing the pitolisant franchise, advancing its CNS pipeline, deploying capital strategically, and protecting WAKIX exclusivity. The company does not currently expect changes in the timing of key commercial and pipeline milestones.
Anastasiou holds an M.B.A. from the Kelley School of Business at Indiana University and a B.A. in economics and management from Albion College.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Harmony Biosciences names Peter Anastasiou as next CEO
View all comments (0)
0
Latest comments
Post
Comment Guidelines
Trade With A Regulated Broker
Indices
Commodities
Bonds
Stocks
US 30
51,695.50
+40.3
+0.08%
US 500
7,813.70
+2.2
+0.03%
Dow Jones
51,654.95
+423.31
+0.83%
S&P 500
7,811.54
+46.18
+0.59%
Nasdaq
27,366.17
+172.83
+0.64%
S&P 500 VIX
15.50
+0.66
+4.45%
Dollar Index
102.21
+0.188
+0.18%
Crude Oil WTI Futures
92.90
+1.05
+1.14%
Brent Oil Futures
105.95
+1.23
+1.17%
Natural Gas Futures
3.145
-0.075
-2.33%
Gold Futures
4,199.51
-16.79
-0.40%
Silver Futures
60.898
-0.151
-0.25%
Copper Futures
6.7673
+0.0753
+1.13%
US Soybeans Futures
1,282.88
-8.13
-0.63%
U.S. 10Y
5.256
+0.012
+0.23%
U.S. 30Y
5.599
-0.008
-0.14%
U.S. 5Y
5.021
+0.030
+0.60%
U.S. 3M
4.159
+0.008
+0.19%
US 10Y T-Note Futures
104.53
-0.06
-0.06%
Euro Bund Futures
121.05
-0.03
-0.03%
10-2 Yield Spread
31.32
+4.15
+15.27%
AAPL
336.64
-3.78
-1.11%
NVDA
229.28
-1.20
-0.52%
GOOGL
351.66
+3.37
+0.97%
TSLA
382.70
+7.70
+2.05%
AMZN
262.43
+8.37
+3.29%
NFLX
70.30
-1.27
-1.77%
META
718.67
-2.22
-0.31%
Advertisement
Most Popular Articles
News
Analysis
Oil falls, CPI and bank earnings in focus - what’s moving markets
By Investing.co
...
Oct 12, 2026
8 emerging markets to consider in 2027: HSBC
By Investing.co
...
Oct 11, 2026
What the sell off in bonds means for monetary policy
By Investing.co
...
Oct 11, 2026
Broadcom CEO says many AI investors are gamblers
By Investing.co
...
Oct 12, 2026
Premarket movers: Iren jumps on Anthropic deal, CCC surges on buyout talks
By Investing.co
...
Oct 12, 2026
Sequence of Return Risk: The Math That Breaks Retirements
By Lance Robert
...
Oct 10, 2026
Beyond Chips: The 3 Layers of the AI Value Chain
By Ivana Delevs
...
Oct 10, 2026
OpenAI’s $20B Revenue Gap: Warning Signs for US Stocks?
By Lee Yang
Oct 09, 2026
Wall Street’s Busy Week: Bank Results, CPI and Retail Sales in Focus
By Ali Merchant
Oct 12, 2026
Treasury Auctions Explained: Why Bond Auctions Matter Even If You Dont Trade Bonds
By Matthew Well
...
Oct 10, 2026
More News
Market Movers
Most Active
Gainers %
Losers %
Name
Last
Chg. %
Vol.
MU
1,029.00
-0.66%
19.92M
NVDA
229.28
-0.52%
84.65M
SPCX
162.57
+1.25%
93.04M
TSLA
382.70
+2.05%
38.95M
AAPL
336.64
-1.11%
37.88M
MSFT
535.07
+2.38%
18.50M
AMZN
262.43
+3.29%
34.77M
Name
Last
Chg. %
Vol.
CCI
79.64
+15.60%
14.39M
MRNA
225.00
+14.21%
28.95M
HUM
431.87
+11.56%
4.99M
AMT
182.24
+9.30%
8.51M
SBAC
182.49
+7.34%
2.36M
DDOG
293.26
+7.11%
3.71M
AKAM
106.95
+6.00%
5.80M
Name
Last
Chg. %
Vol.
TMUS
148.58
-13.27%
19.03M
T
22.18
-10.82%
150.53M
VZ
41.65
-10.14%
95.17M
HPQ
30.20
-6.91%
16.70M
FMC
8.35
-6.39%
5.19M
CHTR
103.38
-5.74%
5.11M
FICO
667.58
-5.63%
1.09M
Advertisement
Trending Stocks
Name
Last
Chg. %
Vol.
MU
1,029.00
-0.66%
19.92M
NVDA
229.28
-0.52%
84.65M
SPCX
162.57
+1.25%
93.04M
PLTR
209.05
+5.17%
37.62M
IREN
35.190
-1.46%
38.53M
Show more
Advertisement
ProPicks AI
AI-powered
stock picks
with a proven track record to
beat the S&P 500
.
Tech Titans
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Top Value Stocks
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Best of Buffett
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Energy Elite
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Financial Fortresses
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Quality Compounders
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Small-Cap Sprinters
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Healthcare Heroes
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Beat the S&P 500
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Dominate the Dow
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Mid-Cap Movers
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Mexican Stock Exchange Leaders
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Best Brazilian Stocks
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Italian Market Elite
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Alpha Germany Select
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Comments
Post
Comment Guidelines
Tools
Calendars
Economic Calendar
Earnings Calendar
Holiday Calendar
US Economy
Fed Rate Monitor Tool
US Treasury Yield Curve
More Tools
Stock Screener
Currency Converter
Markets
Ask WarrenAI
Stocks Picked by AI
Watchlist
Alerts
Top Brokers
Breaking News
Tools
Install Our App
Scan QR code to install app
Follow us
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
3c322b792c· 2026-10-12 19:06 · doubao / doubao-seed-evolving-latest-version · 策略包2226518bfdee当前